The GlySure™ System is a continuous glucose monitoring (CGM) device for critical care that provides clinicians with the real-time and trending data required to optimize glycemic control.*
GlySure’s highly sensitive glucose detection chemistry was developed by a team of scientists with 150 years of combined experience in developing continuous monitoring sensors and systems.
Optimizing glycemic control among critical care patients can lead to improved clinical outcomes, enhanced patient safety and reduced healthcare costs.
*GlySure is CE-marked for use in adult cardiac surgery patients in the critical care setting.